Xinzhen Yang

Title: Innovations by Xinzhen Yang in Human Cytomegalovirus Research

Introduction

Xinzhen Yang is a notable inventor based in Woodcliff Lake, NJ (US). He has made significant contributions to the field of virology, particularly in the study of human cytomegalovirus (HCMV). With a total of two patents to his name, Yang's work focuses on innovative polypeptides and their applications in medical research.

Latest Patents

Yang's latest patents include groundbreaking inventions related to human cytomegalovirus gB polypeptides. The first patent describes polypeptides and cytomegalovirus antigens that incorporate at least one introduced amino acid mutation compared to the wild-type HCMV glycoprotein B (gB). This invention also discusses compositions that include these polypeptides and their potential uses. The second patent focuses on a polypeptide that features at least one mutation in the fusion loop 1 region, fusion loop 2 region, and/or the furin-like cleavage site of the human cytomegalovirus gB polypeptide. This polypeptide is designed to undergo a structural conformation change in response to pH variations.

Career Highlights

Xinzhen Yang is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer allows him to collaborate with other experts in the field and contribute to advancements in virology and vaccine development.

Collaborations

Yang has worked alongside notable colleagues such as Xiaoyuan Sherry Chi and Philip R Dormitzer. These collaborations have further enhanced his research and innovation in the field of human cytomegalovirus.

Conclusion

Xinzhen Yang's contributions to the field of virology through his patents on human cytomegalovirus gB polypeptides demonstrate his commitment to advancing medical research. His work at Pfizer Corporation and collaborations with esteemed colleagues highlight the importance of teamwork in driving innovation.